Starting
Initialising…
0%
BCORL1
Final classification
VUS
BCORL1 c.2361A>T · p.Pro787=
BCORL1

The BCORL1 c.2361A>T (p.Pro787=) variant has not been reported in ClinVar.

Gene
BCORL1
Transcript
NM_021946.4
HGVS · transcript:coding
NM_021946.4:c.2361A>T
Consequence
N/A
GRCh38
chrX:130015133 A>T
GRCh37
chrX:129149109 A>T
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting, BP4 supporting; combination = 1 supporting + 1 supporting benign, which maps to VUS because the evidence is conflicting.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting, BP4 supporting; combination = 1 supporting + 1 supporting benign, which maps to VUS because the evidence is conflicting.
Classification rationale
PM2 BP4 VUS
BCORL1 c.2361A>T

The BCORL1 c.2361A>T (p.Pro787=) variant has not been reported in ClinVar.1 This variant is present in gnomAD at 0.00164% in v2.1 (3/183251 alleles; grpmax FAF 9.75e-06) and 0.00107% in v4.1 (13/1212241 alleles; grpmax FAF 8.1e-06), which is below the default non-VCEP PM2 threshold of 0.1%.2 SpliceAI predicts no significant splice impact for this synonymous variant, with a maximum delta score of 0.00, arguing against a computationally predicted splice-disrupting effect.3

PM2 + BP4 VUS
Gene diagram · NM_021946.4 · variants mapped to exon structure
BCORL1 NM_021946.4
Fetching transcript structure from UCSC…
Applied criteria · 2 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 1.07239e-05; MAF= 0.00107%, 13/1212241 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 1.45152e-05; MAF= 0.00145%, 13/895613 alleles, homozygotes = 0); grpmax FAF= 8.1e-06.
      v2.1
      This variant is present in gnomAD v2.1 (AF= 1.6371e-05; MAF= 0.00164%, 3/183251 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 3.66928e-05; MAF= 0.00367%, 3/81760 alleles, homozygotes = 0); grpmax FAF= 9.75e-06.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      0.0011% · 13 / 1,212,241
      0 hom · FAF 0.00081%
      European (non-Finnish)
      13 / 895,613
      0.0015%
      + 9 not observed (Remaining individuals, Admixed American, European (Finnish), Amish, East Asian, Middle Eastern, South Asian, Ashkenazi Jewish, African/African American)
      gnomAD v2.1
      0.0016% · 3 / 183,251
      0 hom · FAF 0.00097%
      European (non-Finnish)
      3 / 81,760
      0.0037%
      + 7 not observed (African/African American, Admixed American, Ashkenazi Jewish, East Asian, European (Finnish), Remaining individuals, South Asian)
      ClinVar screenshot
      ClinVar
      This variant is absent from ClinVar.
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00).
      Functional / OncoKB screenshot
      Functional Unknown Oncogenic Effect
      OncoKB identified curated literature and non-variant-specific oncogenicity context for review; listed oncogenicity label: Unknown Oncogenic Effect.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Sources & reference links
      7Sources
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots